Dr. Suzette Sutherland

Yeah. Can you refresh my memory? Is there a certain percentage? If it's mixed, is there a certain percentage of high grade to put them into the high grade category, like 5% or is it any high grade?

Yeah. Can you refresh my memory? Is there a certain percentage? If it's mixed, is there a certain percentage of high grade to put them into the high grade category, like 5% or is it any high grade?

Yeah. Can you refresh my memory? Is there a certain percentage? If it's mixed, is there a certain percentage of high grade to put them into the high grade category, like 5% or is it any high grade?

Well, I mean, that's obviously a very important junction then whether a patient is deemed intermediate versus high, getting intravesical chemotherapy or intravesical BCG, and the risks associated with the intravesical therapy, right?

Well, I mean, that's obviously a very important junction then whether a patient is deemed intermediate versus high, getting intravesical chemotherapy or intravesical BCG, and the risks associated with the intravesical therapy, right?

Well, I mean, that's obviously a very important junction then whether a patient is deemed intermediate versus high, getting intravesical chemotherapy or intravesical BCG, and the risks associated with the intravesical therapy, right?

That clinical decision, taking out, you know, all of the objective things and looking at the patient, having the patient help make that decision, what they're willing to do, it's not easy, right? And so, The more we have on the diagnostic end of things to point our fingers towards a high risk situation to tell us to do the intravascular therapy.

That clinical decision, taking out, you know, all of the objective things and looking at the patient, having the patient help make that decision, what they're willing to do, it's not easy, right? And so, The more we have on the diagnostic end of things to point our fingers towards a high risk situation to tell us to do the intravascular therapy.

That clinical decision, taking out, you know, all of the objective things and looking at the patient, having the patient help make that decision, what they're willing to do, it's not easy, right? And so, The more we have on the diagnostic end of things to point our fingers towards a high risk situation to tell us to do the intravascular therapy.

I mean, it obviously makes our job somewhat easier to some degree, right? Because that decision making process is out of it, the judgment part. But also, I think for the patient to accept that. doing intravesical therapy. It's not an easy thing. You do this all the time, right?

I mean, it obviously makes our job somewhat easier to some degree, right? Because that decision making process is out of it, the judgment part. But also, I think for the patient to accept that. doing intravesical therapy. It's not an easy thing. You do this all the time, right?

I mean, it obviously makes our job somewhat easier to some degree, right? Because that decision making process is out of it, the judgment part. But also, I think for the patient to accept that. doing intravesical therapy. It's not an easy thing. You do this all the time, right?

This isn't my specialty, but I do have some bladder cancer patients that are women in my practice, and it's never an easy thing for those women to undergo that and some of the hardships associated with the symptoms thereafter and so on and so forth that they go through, right? So this really would help, you know, make that diagnosis. I found some information on the sensitivity.

This isn't my specialty, but I do have some bladder cancer patients that are women in my practice, and it's never an easy thing for those women to undergo that and some of the hardships associated with the symptoms thereafter and so on and so forth that they go through, right? So this really would help, you know, make that diagnosis. I found some information on the sensitivity.

This isn't my specialty, but I do have some bladder cancer patients that are women in my practice, and it's never an easy thing for those women to undergo that and some of the hardships associated with the symptoms thereafter and so on and so forth that they go through, right? So this really would help, you know, make that diagnosis. I found some information on the sensitivity.

the accuracy, right? Looking at what's seen through the eye and then what's seen histologically. And with white light, the accuracy is 76% compared to blue light, 91%. And then combination, white plus blue, 98.5%. Now, clearly that comes from, I'm sure, one conglomerate study of looking at things. But still, the difference there is really poignant.

the accuracy, right? Looking at what's seen through the eye and then what's seen histologically. And with white light, the accuracy is 76% compared to blue light, 91%. And then combination, white plus blue, 98.5%. Now, clearly that comes from, I'm sure, one conglomerate study of looking at things. But still, the difference there is really poignant.

the accuracy, right? Looking at what's seen through the eye and then what's seen histologically. And with white light, the accuracy is 76% compared to blue light, 91%. And then combination, white plus blue, 98.5%. Now, clearly that comes from, I'm sure, one conglomerate study of looking at things. But still, the difference there is really poignant.

And why do you say that? Is that more for our learning purposes? So then we can go back and say, this is what it looked like in white, and now I see it on blue. So ergo, next time I'm going to know that white light, little distal I didn't think was important, is important, or is there more to it?

And why do you say that? Is that more for our learning purposes? So then we can go back and say, this is what it looked like in white, and now I see it on blue. So ergo, next time I'm going to know that white light, little distal I didn't think was important, is important, or is there more to it?